{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T19:40:16Z","timestamp":1793907616782,"version":"4.8.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100001006","name":"Breast Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA008748"],"award-info":[{"award-number":["P30CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.ygyno.2018.10.032","type":"journal-article","created":{"date-parts":[[2018,11,8]],"date-time":"2018-11-08T17:43:54Z","timestamp":1541699034000},"page":"11-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":97,"title":["Analysis of mutational signatures in primary and metastatic endometrial cancer reveals distinct patterns of DNA repair defects and shifts during tumor progression"],"prefix":"10.1016","volume":"152","author":[{"given":"Charles W.","family":"Ashley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Da Cruz Paula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Mandelker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadeem","family":"Riaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge S.","family":"Reis-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britta","family":"Weigelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2018.10.032_bb0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21442","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ygyno.2018.10.032_bb0010","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djx030","article-title":"Annual report to the nation on the status of cancer, 1975\u20132014, featuring survival","volume":"109","author":"Jemal","year":"2017","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2018.10.032_bb0015","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Cancer Genome Atlas Research Network","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ygyno.2018.10.032_bb0020","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ygyno.2017.10.037","article-title":"An NRG oncology\/GOG study of molecular classification for risk prediction in endometrioid endometrial cancer","volume":"148","author":"Cosgrove","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.10.032_bb0025","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ccell.2017.02.010","article-title":"Integrated molecular characterization of uterine carcinosarcoma","volume":"31","author":"Cherniack","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ygyno.2018.10.032_bb0030","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/ng.3602","article-title":"The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis","volume":"48","author":"Gibson","year":"2016","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ygyno.2018.10.032_bb0035","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ygyno.2018.10.032_bb0040","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1158\/1078-0432.CCR-16-2810","article-title":"Mutational signatures in breast cancer: the problem at the DNA level","volume":"23","author":"Nik-Zainal","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2018.10.032_bb0045","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nrg3729","article-title":"Mechanisms underlying mutational signatures in human cancers","volume":"15","author":"Helleday","year":"2014","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.ygyno.2018.10.032_bb0050","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1002\/cncr.31112","article-title":"Physician interpretation of genomic test results and treatment selection","volume":"124","author":"Brusco","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2018.10.032_bb0055","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.ccell.2018.03.014","article-title":"A comprehensive pan-cancer molecular study of gynecologic and breast cancers","volume":"33","author":"Berger","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ygyno.2018.10.032_bb0060","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1126\/science.1253462","article-title":"Spatial and temporal diversity in genomic instability processes defines lung cancer evolution","volume":"346","author":"de Bruin","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.ygyno.2018.10.032_bb0065","doi-asserted-by":"crossref","first-page":"4402","DOI":"10.1158\/1078-0432.CCR-16-3115","article-title":"Genetic heterogeneity in therapy-naive synchronous primary breast cancers and their metastases","volume":"23","author":"Ng","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2018.10.032_bb0070","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.cell.2018.02.060","article-title":"Comprehensive characterization of cancer driver genes and mutations","volume":"173","author":"Bailey","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.ygyno.2018.10.032_bb0075","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","author":"Cancer Genome Atlas Research Network","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ygyno.2018.10.032_bb0080","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nature11412","article-title":"Comprehensive molecular portraits of human breast tumours","volume":"490","author":"Cancer Genome Atlas Network","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ygyno.2018.10.032_bb0085","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13059-016-0893-4","article-title":"DeconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution","volume":"17","author":"Rosenthal","year":"2016","journal-title":"Genome Biol."},{"key":"10.1016\/j.ygyno.2018.10.032_bb0090","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1093\/jnci\/djy028","article-title":"The landscape of somatic genetic alterations in breast cancers from ATM germline mutation carriers","volume":"110","author":"Weigelt","year":"2018","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2018.10.032_bb0095","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ygyno.2018.05.008","article-title":"Massively parallel sequencing analysis of mucinous ovarian carcinomas: genomic profiling and differential diagnoses","volume":"150","author":"Mueller","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.10.032_bb0100","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/bioinformatics\/btt755","article-title":"MSIsensor: microsatellite instability detection using paired tumor-normal sequence data","volume":"30","author":"Niu","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ygyno.2018.10.032_bb0105","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.cell.2018.03.022","article-title":"Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer","volume":"173","author":"Hoadley","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.ygyno.2018.10.032_bb0110","doi-asserted-by":"crossref","first-page":"5454","DOI":"10.1158\/0008-5472.CAN-12-1470","article-title":"Ploidy and large-scale genomic instability consistently identify basal-like breast carcinomas with BRCA1\/2 inactivation","volume":"72","author":"Popova","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2018.10.032_bb0115","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/s41467-017-00921-w","article-title":"Pan-cancer analysis of bi-allelic alterations in homologous recombination DNA repair genes","volume":"8","author":"Riaz","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ygyno.2018.10.032_bb0120","article-title":"The repertoire of mutational signatures in human cancer","author":"Alexandrov","year":"2018","journal-title":"BioRxiv"},{"key":"10.1016\/j.ygyno.2018.10.032_bb0125","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkw520","article-title":"FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing","volume":"44","author":"Shen","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ygyno.2018.10.032_bb0130","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nbt.2203","article-title":"Absolute quantification of somatic DNA alterations in human cancer","volume":"30","author":"Carter","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ygyno.2018.10.032_bb0135","doi-asserted-by":"crossref","first-page":"14114","DOI":"10.1038\/ncomms14114","article-title":"Reconstructing metastatic seeding patterns of human cancers","volume":"8","author":"Reiter","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ygyno.2018.10.032_bb0140","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/path.5081","article-title":"Somatic POLE exonuclease domain mutations are early events in sporadic endometrial and colorectal carcinogenesis, determining driver mutational landscape, clonal neoantigen burden and immune response","volume":"245","author":"Temko","year":"2018","journal-title":"J. Pathol."},{"key":"10.1016\/j.ygyno.2018.10.032_bb0145","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1101\/gr.219915.116","article-title":"Human mismatch repair system balances mutation rates between strands by removing more mismatches from the lagging strand","volume":"27","author":"Andrianova","year":"2017","journal-title":"Genome Res."},{"key":"10.1016\/j.ygyno.2018.10.032_bb0150","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1038\/s41467-018-04002-4","article-title":"Distinct mutational signatures characterize concurrent loss of polymerase proofreading and mismatch repair","volume":"9","author":"Haradhvala","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ygyno.2018.10.032_bb0155","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/gim.2015.75","article-title":"POLE and POLD1 mutations in 529 kindred with familial colorectal cancer and\/or polyposis: review of reported cases and recommendations for genetic testing and surveillance","volume":"18","author":"Bellido","year":"2016","journal-title":"Genet. Med."},{"key":"10.1016\/j.ygyno.2018.10.032_bb0160","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/cncr.29046","article-title":"Polymerase varepsilon (POLE) mutations in endometrial cancer: clinical outcomes and implications for Lynch syndrome testing","volume":"121","author":"Billingsley","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2018.10.032_bb0165","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1038\/onc.2009.33","article-title":"Familial breast cancer screening reveals an alteration in the RAP80 UIM domain that impairs DNA damage response function","volume":"28","author":"Nikkila","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.ygyno.2018.10.032_bb0170","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/path.5034","article-title":"The rise of a novel classification system for endometrial carcinoma; integration of molecular subclasses","volume":"244","author":"McAlpine","year":"2018","journal-title":"J. Pathol."},{"key":"10.1016\/j.ygyno.2018.10.032_bb0175","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1158\/1078-0432.CCR-18-0266","article-title":"Adjuvant treatment for POLE proofreading domain-mutant cancers: sensitivity to radiotherapy, chemotherapy, and nucleoside analogues","volume":"24","author":"Van Gool","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2018.10.032_bb0180","doi-asserted-by":"crossref","first-page":"90532","DOI":"10.18632\/oncotarget.20042","article-title":"Checkpoint inhibitors in endometrial cancer: preclinical rationale and clinical activity","volume":"8","author":"Mittica","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ygyno.2018.10.032_bb0185","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1056\/NEJMp1709968","article-title":"First FDA approval agnostic of cancer site - when a biomarker defines the indication","volume":"377","author":"Lemery","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2018.10.032_bb0190","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ygyno.2015.01.541","article-title":"Detection of DNA mismatch repair (MMR) deficiencies by immunohistochemistry can effectively diagnose the microsatellite instability (MSI) phenotype in endometrial carcinomas","volume":"137","author":"McConechy","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.10.032_bb0195","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3389\/fonc.2018.00016","article-title":"Role of BRCA mutations in the modulation of response to platinum therapy","volume":"8","author":"Mylavarapu","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ygyno.2018.10.032_bb0200","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1634\/theoncologist.2016-0062","article-title":"Chemotherapy for endometrial cancer in adjuvant and advanced disease settings","volume":"21","author":"Bestvina","year":"2016","journal-title":"Oncologist"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825818313167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825818313167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,2]],"date-time":"2019-01-02T08:51:42Z","timestamp":1546419102000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825818313167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0090825818313167"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2018.10.032","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of mutational signatures in primary and metastatic endometrial cancer reveals distinct patterns of DNA repair defects and shifts during tumor progression","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2018.10.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}